Chronic Myelogenous Leukemia News and Research

RSS
Chronic myeloid leukemia (CML) is also known as chronic myelogenous leukemia. According to the American Cancer Society, CML is a type of cancer that starts in blood-forming cells of the bone marrow and then invades the blood. It can spread to the lymph nodes, spleen, liver, and other parts of the body. CML can also change into a fast-growing acute leukemia that invades almost any organ in the body.
NYUCI experts present latest research findings about hematologic cancers at 53rd ASH meeting

NYUCI experts present latest research findings about hematologic cancers at 53rd ASH meeting

Researchers discover potential target for cherubism

Researchers discover potential target for cherubism

Novartis to showcase 160 presentations on breast cancer, hematological disease drugs at SABCS and ASH

Novartis to showcase 160 presentations on breast cancer, hematological disease drugs at SABCS and ASH

John Theurer Cancer Center to present results of 31 studies at ASH 2011 meeting

John Theurer Cancer Center to present results of 31 studies at ASH 2011 meeting

New method reveals complete set of aberrant signaling pathways that give rise to cancers

New method reveals complete set of aberrant signaling pathways that give rise to cancers

New data from Pfizer's hematology portfolio to be presented at 53rd ASH annual meeting

New data from Pfizer's hematology portfolio to be presented at 53rd ASH annual meeting

ARIAD reports net income of $13.9 million for third quarter 2011

ARIAD reports net income of $13.9 million for third quarter 2011

Age is no longer a barrier to allogeneic stem cell transplantation

Age is no longer a barrier to allogeneic stem cell transplantation

Asuragen introduces ARQ IS Calibrator Panels to improve BCR-ABL1 testing for CML

Asuragen introduces ARQ IS Calibrator Panels to improve BCR-ABL1 testing for CML

Long-term results from ARIAD's ponatinib Phase 1 study on CML and Ph+ ALL

Long-term results from ARIAD's ponatinib Phase 1 study on CML and Ph+ ALL

Regulatory bias against taking oral anti-cancer medications with food places patients at risk of overdose

Regulatory bias against taking oral anti-cancer medications with food places patients at risk of overdose

Researchers discover new genetic defect that predisposes people to leukemia, myelodysplasia

Researchers discover new genetic defect that predisposes people to leukemia, myelodysplasia

Researchers discover NPC1 protein as crucial for Ebola virus to enter host cells

Researchers discover NPC1 protein as crucial for Ebola virus to enter host cells

EMA accepts Pfizer's regulatory submissions of two investigational cancer drugs for review

EMA accepts Pfizer's regulatory submissions of two investigational cancer drugs for review

ARIAD reports $47.8 million net loss for second quarter 2011

ARIAD reports $47.8 million net loss for second quarter 2011

NanoString introduces new assay for leukemia fusion gene analysis

NanoString introduces new assay for leukemia fusion gene analysis

Health Canada approves SPRYCEL as first-line treatment for life-threatening blood cancer

Health Canada approves SPRYCEL as first-line treatment for life-threatening blood cancer

Medco announces new offerings within Advanced Oncology Solutions

Medco announces new offerings within Advanced Oncology Solutions

Indirubin might help treat glioblastoma

Indirubin might help treat glioblastoma

Common cell pathway could lead to new treatments for autoimmune diseases and cancer

Common cell pathway could lead to new treatments for autoimmune diseases and cancer